Annual Drug Patent Expirations for FIASP+FLEXTOUCH
Fiasp Flextouch is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug.
This drug has one hundred and fourteen patent family members in twenty-one countries.
Copyright © DrugPatentWatch. Originally published at Patent delisted for NOVO drug FIASP FLEXTOUCH